Literature DB >> 3181404

The humoral immune response after BCG vaccination in humans: consequences for the serodiagnosis of tuberculosis.

M Turneer1, J P Van Vooren, J Nyabenda, F Legros, A Lecomte, J Thiriaux, E Serruys, J C Yernault.   

Abstract

The IgM and IgG response to BCG vaccination was investigated in 75 adults, tuberculin negative before vaccination, using an enzyme-linked immunosorbent assay with purified protein derivative (PPD) as antigen. The mean optical density (OD) increased significantly (p less than 0.001) in both immunoglobulin classes. Increase in at least one class was significant in 89% of the subjects. The observed increase in anti-PPD IgG was rather small but comparable to that seen in 17 newly diagnosed tuberculosis patients with negative direct smear [mean OD (SD): 0.59 (0.38) in vaccinated and 0.70 (0.48) in patients] but significantly lower (p less than 0.001) than that seen in 31 newly diagnosed patients with positive direct smear [mean OD (SD): 1.07 (0.67)]. With 55% of sera above the upper normal limit, smear positive patients differentiated (p less than 0.001) from vaccinated subjects (20% of positive sera) whilst smear negative patients (29% of positive sera) did not. We conclude that BCG vaccination induces a definite but small increase in anti-PPD serum IgM and IgG, which is likely to interfere when interpreting serological tests for the diagnosis of tuberculosis, especially in those patients who would most benefit from an early and fast diagnosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181404

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  8 in total

1.  The pattern of mycobacterial antigen recognition in sera from Mantoux-negative individuals is essentially unaffected by bacille Calmette-Guérin (BCG) vaccination in either south India or London.

Authors:  S Das; S H Cheng; D B Lowrie; K B Walker; D A Mitchison; R S Vallishayee; P R Narayanan
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Humoral immune response against antigen 60 in BCG-vaccinated infants.

Authors:  S Rota; U Beyazova; T Karsligil; C Cevheroğlu
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

3.  Epidemiology of the M-component immunoglobulin types of multiple myeloma.

Authors:  L J Herrinton; P A Demers; T D Koepsell; N S Weiss; J R Daling; J W Taylor; J L Lyon; G M Swanson; R S Greenberg
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

Review 4.  The Humoral Immune Response to BCG Vaccination.

Authors:  Rachel Tanner; Bernardo Villarreal-Ramos; H Martin Vordermeier; Helen McShane
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

5.  First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment.

Authors:  Daria V Vasina; Denis A Kleymenov; Victor A Manuylov; Elena P Mazunina; Egor Yu Koptev; Elena A Tukhovskaya; Arkady N Murashev; Alexander L Gintsburg; Vladimir A Gushchin; Artem P Tkachuk
Journal:  Vaccines (Basel)       Date:  2019-11-01

6.  Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection.

Authors:  Rachel Tanner; Iman Satti; Stephanie A Harris; Matthew K O'Shea; Deniz Cizmeci; Daniel O'Connor; Agnieszka Chomka; Magali Matsumiya; Rachel Wittenberg; Angela M Minassian; Joel Meyer; Helen A Fletcher; Helen McShane
Journal:  Front Immunol       Date:  2020-01-10       Impact factor: 7.561

Review 7.  TB vaccine development and the End TB Strategy: importance and current status.

Authors:  Helen A Fletcher; Lewis Schrager
Journal:  Trans R Soc Trop Med Hyg       Date:  2016-04       Impact factor: 2.184

8.  Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination.

Authors:  Julia Bitencourt; Marco Polo Peralta-Álvarez; Morven Wilkie; Ashley Jacobs; Daniel Wright; Salem Salman Almujri; Shuailin Li; Stephanie A Harris; Steven G Smith; Sean C Elias; Andrew D White; Iman Satti; Sally S Sharpe; Matthew K O'Shea; Helen McShane; Rachel Tanner
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.